BIOREM Stock Forecast, Price & News

-0.02 (-4.44 %)
(As of 07/30/2021 03:08 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume13,000 shs
Average Volume25,095 shs
Market CapitalizationC$16.62 million
P/E Ratio17.20
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BRM News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOREM and its competitors with MarketBeat's FREE daily newsletter.


BIOREM Inc., a clean technology engineering company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs and HAPs; and biotrickling filters for applications of high levels of H2S or other water soluble VOCs. The company also provides multi-stage systems to treat odors associated with various municipal wastewater treatment processes; biogas desulfurization systems; dry scrubber; and biological odor control systems to treat air emissions. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BIOREM Inc. is headquartered in Guelph, Canada.


BIOREM Reports Second Quarter 2021 Financial Results
BIOREM Reports Second Quarter 2021 Financial Results
July 28, 2021 |
Biorem Reports $2.1 million Earnings for Fiscal 2020
Biorem Reports $2.1 million Earnings for Fiscal 2020
March 31, 2021 |
Bye, Orem
Bye, Orem
March 4, 2021 |
BIOREM Reports 2020 Second Quarter Results
BIOREM Reports 2020 Second Quarter Results
August 11, 2020 |
Biorem Reports First Quarter Financial Results
Biorem Reports First Quarter Financial Results
June 24, 2020 |
BIOREM Announces Delay in Filing Interim Financial Statements
BIOREM Announces Delay in Filing Interim Financial Statements
May 29, 2020 |
BIOREM Announces Delay in Filing Annual Financial Statements
BIOREM Announces Delay in Filing Annual Financial Statements
April 29, 2020 |
Is BIOREM Inc.s (CVE:BRM) CEO Paid At A Competitive Rate?
Is BIOREM Inc.'s (CVE:BRM) CEO Paid At A Competitive Rate?
February 7, 2020 |
Why You Should Like BIOREM Inc.’s (CVE:BRM) ROCE
Why You Should Like BIOREM Inc.’s (CVE:BRM) ROCE
December 24, 2019 |
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.08 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

BIOREM (CVE:BRM) Frequently Asked Questions

What stocks does MarketBeat like better than BIOREM?

Wall Street analysts have given BIOREM a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BIOREM wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is BIOREM's next earnings date?

BIOREM is scheduled to release its next quarterly earnings announcement on Wednesday, November 24th 2021.
View our earnings forecast for BIOREM

How were BIOREM's earnings last quarter?

BIOREM Inc. (CVE:BRM) posted its quarterly earnings results on Wednesday, May, 19th. The company reported ($0.01) EPS for the quarter. The company had revenue of $3.43 million for the quarter.
View BIOREM's earnings history

How has BIOREM's stock been impacted by Coronavirus?

BIOREM's stock was trading at C$0.38 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BRM stock has increased by 14.7% and is now trading at C$0.43.
View which stocks have been most impacted by COVID-19

Who are BIOREM's key executives?

BIOREM's management team includes the following people:
  • Mr. Derek S. Webb, CEO, Pres & Director
  • Mr. Douglas Newman, CFO & Sec.

Who are some of BIOREM's key competitors?

What other stocks do shareholders of BIOREM own?

What is BIOREM's stock symbol?

BIOREM trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BRM."

How do I buy shares of BIOREM?

Shares of BRM and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is BIOREM's stock price today?

One share of BRM stock can currently be purchased for approximately C$0.43.

How much money does BIOREM make?

BIOREM has a market capitalization of C$16.62 million and generates C$20.58 million in revenue each year.

What is BIOREM's official website?

The official website for BIOREM is

Where are BIOREM's headquarters?

BIOREM is headquartered at 7496 Wellington Road 34, R.R. #3, GUELPH, ON N1H 6H9, Canada.

How can I contact BIOREM?

BIOREM's mailing address is 7496 Wellington Road 34, R.R. #3, GUELPH, ON N1H 6H9, Canada. The company can be reached via phone at +1-519-7679100.

This page was last updated on 8/2/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.